Fund Holdings — Catalio Capital Management, LP

Total Portfolio Value:
$403.35M
Total Bought:
$131.05M
Total Sold:
$165.77M
Net Transaction:
-$34.71M
Notable People:
Catalio Capital Gp, Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Becton, Dickinson and Company(BDX)148,615203,965+55,350$33.72M$46.72M11.58%+$13.00M
Springworks Therapeutics Inc764,668758,533-6,135$27.63M$33.47M8.30%+$5.85M
BridgeBio Pharma, Inc.(BBIO)898,458962,883+64,425$24.65M$33.29M8.25%+$8.63M
Edwards Lifesciences Corp333,144435,588+102,444$24.66M$31.57M7.83%+$6.91M
Ascendis Pharma A/SADR(ASND)215,587195,523-20,064$29.68M$30.47M7.56%+$794.4K
Cytokinetics, Incorporated(CYTK)457,587585,812+128,225$21.52M$23.54M5.84%+$2.02M
Veracyte, Inc.(VCYT)490,547762,225+271,678$19.43M$22.60M5.60%+$3.17M
Syndax Pharmaceuticals, Inc.(SNDX)01,733,701+1,733,701$0$21.30M5.28%+$21.30M
Eli Lilly and Company(LLY)023,682+23,682$0$19.56M4.85%+$19.56M
Intuitive Surgical, Inc.(ISRG)36,91036,499-411$19.27M$18.08M4.48%-$1.19M
LivaNova PLCSHS(LIVN)512,447381,648-130,799$23.73M$14.99M3.72%-$8.74M
Dianthus Therapeutics, Inc.(DNTH)763,471763,4710$16.64M$13.85M3.43%-$2.79M
Inspire Medical Systems, Inc.(INSP)085,877+85,877$0$13.68M3.39%+$13.68M
Structure Therapeutics IncADS569,395704,864+135,469$15.44M$12.20M3.02%-$3.24M
Soleno Therapeutics Inc0160,962+160,962$0$11.50M2.85%+$11.50M
uniQure N.V.SHS(QURE)901,973830,325-71,648$15.93M$8.80M2.18%-$7.13M
Regeneron Pharmaceuticals, Inc.(REGN)012,261+12,261$0$7.78M1.93%+$7.78M
Septerna, Inc.(SEPN)1,024,2451,024,2450$23.46M$5.93M1.47%-$17.52M
Protara Therapeutics, Inc.(TARA)1,088,6911,088,6910$5.75M$4.64M1.15%-$1.11M
Adaptive Biotechnologies Corporation(ADPT)0611,639+611,639$0$4.54M1.13%+$4.54M
MoonLake ImmunotherapeuticsCL A(MLTX)0114,616+114,616$0$4.48M1.11%+$4.48M
Keros Therapeutics, Inc.(KROS)407,292389,384-17,908$6.45M$3.97M0.98%-$2.48M
Vir Biotechnology, Inc.(VIR)0611,608+611,608$0$3.96M0.98%+$3.96M
Replimune Group, Inc.(REPL)0355,640+355,640$0$3.47M0.86%+$3.47M
Zenas BioPharma, Inc.(ZBIO)187,184295,148+107,964$1.53M$2.33M0.58%+$798.6K
Outset Medical, Inc.(OM)0166,666+166,666$0$1.84M0.46%+$1.84M
Kyverna Therapeutics, Inc.(KYTX)586,909586,9090$2.20M$1.13M0.28%-$1.06M
Metagenomi Therapeutics, Inc.(MGX)528,993528,9930$1.91M$719.4K0.18%-$1.19M
Mersana Therapeutics Inc1,705,0361,705,0360$2.44M$586.9K0.15%-$1.85M
Fulcrum Therapeutics, Inc.(FULC)0202,139+202,139$0$582.2K0.14%+$582.2K
Karyopharm Therapeutics Inc.(KPTI)0155,622+155,622$0$582.0K0.14%+$582.0K
Hyperfine, Inc.CL A(HYPR)760,035760,0350$668.8K$544.4K0.13%-$124.4K
Atai Life Sciences NvSHS196,858196,8580$261.8K$267.7K0.07%+$5.9K
Fractyl Health, Inc.(GUTS)214,236214,2360$441.3K$254.9K0.06%-$186.4K
Faeth Therapeutics, Inc.(FTH)294,374294,3740$144.3K$116.0K0.03%-$28.3K
Adma Biologics Inc512,7240-512,724$8.79M$0—-$8.79M
Blueprint Medicines Corp284,6540-284,654$24.83M$0—-$24.83M
Boston Scientific Corporation(BSX)72,9250-72,925$6.51M$0—-$6.51M
Bristol-Myers Squibb Company(BMY)499,1510-499,151$28.23M$0—-$28.23M
Disc Medicine, Inc.(IRON)179,8150-179,815$11.40M$0—-$11.40M
Envista Holdings Corporation(NVST)1,019,5290-1,019,529$19.67M$0—-$19.67M
Endeavour Silver Corp.(EXK)309,1030-309,103$17.37M$0—-$17.37M
Inari Med Inc132,5450-132,545$6.77M$0—-$6.77M
Karyopharm Therapeutics Inc.(KPTI)2,334,3750-2,334,375$1.58M$0—-$1.58M
Masimo Corp87,3770-87,377$14.44M$0—-$14.44M
Page 1 of 1
Catalio Capital Management, LP — 13F Holdings — Q1 2025 | TickerTrail